Skip to main content
CLNN
NASDAQ Life Sciences

Former Board Member Files Intent to Sell $477K in Clene Inc. Shares Amid Going Concern Warning

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
8
Price
$5.67
Mkt Cap
$67.49M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

Symbiosis II LLC, a former board member of Clene Inc., has filed a Form 144 indicating intent to sell 82,212 shares worth approximately $477,000, continuing a pattern of significant share dispositions.


check_boxKey Events

  • Proposed Share Sale

    Symbiosis II LLC, a former board member, intends to sell 82,212 common shares valued at approximately $477,000.

  • Continuation of Selling Pattern

    This proposed sale follows over $1.3 million in share sales by the same entity in the past three months, indicating a sustained distribution.

  • Financial Distress Context

    The selling occurs shortly after Clene Inc. disclosed "substantial doubt about its ability to continue as a going concern" in its recent 10-K filing.


auto_awesomeAnalysis

This Form 144 filing signals continued distribution by Symbiosis II LLC, a former board member, who has already sold over $1.3 million in shares in the past three months. The proposed sale of an additional $477,000 worth of shares is a substantial transaction for Clene Inc., representing approximately 0.7% of its market capitalization. This ongoing insider selling is particularly concerning given the company's recent 10-K filing, which disclosed "substantial doubt about its ability to continue as a going concern." While the company recently secured an oversubscribed financing, the persistent selling by a former insider, especially one with prior board insight, could be interpreted as a lack of confidence in the company's long-term prospects and adds to the negative sentiment surrounding its financial stability.

At the time of this filing, CLNN was trading at $5.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.5M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 17, 2026, 8:17 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 15, 2026, 4:05 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Apr 10, 2026, 4:06 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CLNN
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CLNN
Mar 31, 2026, 5:05 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Mar 31, 2026, 4:35 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Mar 24, 2026, 4:36 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Mar 17, 2026, 7:00 AM EDT
Filing Type: 10-K
Importance Score:
9
CLNN
Mar 16, 2026, 6:15 PM EDT
Filing Type: 8-K
Importance Score:
8